Dyslipidemia is associated with sarcopenia of the elderly: a meta-analysis
Open Access
- 23 February 2024
- journal article
- research article
- Published by Springer Nature in BMC Geriatrics
- Vol. 24 (1) , 1-11
Abstract
Purpose: Sarcopenia is a pathological change characterized by muscle loss in older people. According to the reports, there is controversy on the relationship between dyslipidemia and sarcopenia. Therefore, this meta-analysis aimed to explore the association between sarcopenia and dyslipidemia. Methods: We searched the Cochrane Library, Web of Science, PubMed, China National Knowledge Infrastructure (CNKI), Wan Fang, China Science and Technology Journal Database (VIP Database) for case‒control studies to extract data on the odds ratio (OR) between sarcopenia and dyslipidemia and the MD(mean difference) of TC, LDL-C, HDL-C, TG, and TG/HDL-C between sarcopenia and nonsarcopenia. The JBI(Joanna Briggs) guidelines were used to evaluate the quality. Excel 2021, Review Manager 5.3 and Stata 16.0 were used for the statistical analysis. Results: Twenty studies were included in the meta-analysis, 19 of which were evaluated as good quality. The overall OR of the relationship between sarcopenia and dyslipidemia was 1.47, and the MD values of TC, LDL-C, HDL-C, TG, and TG/HDL-C were 1.10, 1.95, 1.27, 30.13, and 0.16 respectively. In female, compared with the non-sarcopnia, the MD of TC, LDL-C, HDL-C, TG of sarcopenia were − 1.67,2.21,1.02,-3.18 respectively. In male, the MD of TC, LDL-C, HDL-C, TG between sarcopenia and non-sarcopenia were − 0.51, 1.41, 5.77, -0.67. The OR between sarcopenia and dyslipidemia of the non-China region was 4.38, and it was 0.9 in China. In the group(> 60), MD of TC between sarcopenia and non-sarcopenia was 2.63, while it was 1.54 in the group(20–60). Conclusion: Dyslipidemia was associated with sarcopenia in the elderly, which was affected by sex, region and age.Keywords
All Related Versions
Funding Information
- Beijing High level Public Health Technical Talents Training Plan (2022-1-005, Key Discipline Member-02-44, 2022-1-005, Key Discipline Member-02-44, 2022-1-005, Key Discipline Member-02-44, 2022-1-005, Key Discipline Member-02-44, 2022-1-005, Key Discipline Member-02-44, 2022-1-005, Key Discipline Member-02-44, 2022-1-005, Key Discipline Member-02-44)
This publication has 15 references indexed in Scilit:
- Reporting quality and risk of bias in JBI systematic reviews evaluating the effectiveness of interventions: a methodological review protocolJBI Evidence Synthesis, 2023
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Relationship between muscle mass index and LDL cholesterol target levels: Analysis of two studies of the Korean populationAtherosclerosis, 2021
- Association of Sarcopenia with Metabolic Syndrome in Korean Population Using 2009–2010 Korea National Health and Nutrition Examination SurveyMetabolic Syndrome and Related Disorders, 2019
- Association between Sarcopenia, Sarcopenic Obesity, and Chronic Disease in Korean ElderlyJournal of Bone Metabolism, 2018
- Potential early biomarkers of sarcopenia among independent older adultsMaturitas, 2017
- The increased risk of sarcopenia in patients with cardiovascular risk factors in Suburb-Dwelling older Chinese using the AWGS definitionScientific Reports, 2017
- Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination SurveyJournal of Endocrinological Investigation, 2014
- Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese womenEuropean Journal of Clinical Nutrition, 2012
- Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and MenNew England Journal of Medicine, 2011